Merck

Merck’s 60% price cut for hepatitis C drug nets company a big sales opportunity
Marketwatch
Wed, 08/8/18 - 12:00 am
Merck
Express Scripts
hepatitis C
Zepatier
Two Pharma Giants Successfully Navigate a Challenging Climate
Yahoo/Zacks.com
Sat, 08/4/18 - 11:57 am
Donald Trump
drug pricing
Merck
Amgen
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Fierce Pharma
Fri, 08/3/18 - 11:33 am
Merck
Eisai
Lenvima
kidney cancer
thyroid cancer
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
CP Wire
Fri, 08/3/18 - 09:25 am
AstraZeneca
Merck
selumetinib
Array Biopharma
orphan drugs
NF1
neurofibromatosis
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
Fri, 08/3/18 - 09:23 am
AstraZeneca
Merck
selumetinib
Array Biopharma
Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead
Fierce Pharma
Tue, 07/31/18 - 12:36 pm
Merck
Gardasil
vaccines
HPV
HitGen and Merck Expand Collaboration to Build Novel DNA-Ecoded Libraries for Drug Discovery
CP Wire
Mon, 07/30/18 - 09:49 am
HitGen
DNA
Merck
drug discovery
HitGen and Merck Expand Collaboration to Build Novel DNA-Ecoded Libraries for Drug Discovery
Mon, 07/30/18 - 09:28 am
HitGen
Merck
After an epic battle of blockbusters, Merck leapfrogs Bristol-Myers to take the lead on PD-1/L1 market
Endpoints
Sat, 07/28/18 - 01:02 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
anti-PD-L1
Merck Beats Estimates and Raises Guidance, But Stock Plops 2%
TheStreet.com
Fri, 07/27/18 - 12:17 pm
Merck
earnings
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
RAPS.org
Thu, 07/26/18 - 07:28 pm
Novartis
Merck
GSK
Gilead Sciences
Bayer
AstraZeneca
AbbVie
Takeda
FDA
DDIs
drug-drug interactions
proton pump inhibitors
Days after Merck deal, Sutro rolls out $85M E round to fund internal cancer pipeline
Endpoints
Thu, 07/26/18 - 07:05 pm
Sutro BioPharma
cancer
Merck
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma
CP Wire
Thu, 07/26/18 - 11:47 am
Merck
Keytruda
melanoma
China
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma
Thu, 07/26/18 - 09:47 am
Merck
Keytruda
melanoma
Merck claims a needed win for Keytruda with interim OS data in head and neck cancer
Endpoints
Wed, 07/25/18 - 11:03 am
Merck
Keytruda
clinical trials
squamous cell carcinoma of the head and neck
U.K. to offer Merck's Gardasil to boys after years of protests
Fierce Pharma
Tue, 07/24/18 - 06:51 pm
UK
Merck
Gardasil
HPV
vaccines
Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
CP Wire
Tue, 07/24/18 - 10:11 am
Merck
Doravirine
HIV
Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
Tue, 07/24/18 - 09:55 am
Merck
Doravirine
HIV
Merck touts a 60% price cut, but the drug is outdated and on the way out
Marketwatch
Sat, 07/21/18 - 02:09 pm
Merck
Zepatier
hepatitis C
drug pricing
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze: analysts
Fierce Pharma
Fri, 07/20/18 - 11:59 am
Merck
Pfizer
drug pricing
Donald Trump

Pages